Incorporation of Tumor-Targeting Peptides into Recombinant Adeno-associated Virus Capsids
Open Access
- 1 June 2001
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 3 (6), 964-975
- https://doi.org/10.1006/mthe.2001.0345
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Adeno-associated virus vector-mediated gene transfer to somatic cells in the central nervous systemPublished by Elsevier ,2000
- AAV vectors: is clinical success on the horizon?Gene Therapy, 2000
- Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab'γ)2 antibodyNature Biotechnology, 1999
- Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2Nature Medicine, 1999
- Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectorsNature Genetics, 1997
- Gene Transfer by Adeno-Associated Virus Vectors into the Central Nervous SystemExperimental Neurology, 1997
- Recombinant adeno-associated virus for muscle directed gene therapyNature Medicine, 1997
- Differential expression in human cells from the p6 promoter of human parvovirus B19 following plasmid transfection and recombinant adeno-associated virus 2 (AAV) infection: human megakaryocytic leukaemia cells are non-permissive for AAV infectionJournal of General Virology, 1996
- Adeno-Associated Virus Type 2 Binds to a 150-Kilodalton Cell Membrane GlycoproteinVirology, 1996
- Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector.Proceedings of the National Academy of Sciences, 1993